Celldex Therapeutics Stock Forecast

Buy or Hold candidate since Jun 11, 2026 Gain 7.88%

The Celldex Therapeutics stock price gained 0.623% on the last trading day (Tuesday, 16th Jun 2026), rising from $32.12 to $32.32. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 3.28% from a day low at $31.41 to a day high of $32.44. The price has risen in 7 of the last 10 days and is up by 11.83% over the past 2 weeks. Volume fell on the last day by -189 thousand shares and in total, 789 thousand shares were bought and sold for approximately $25.50 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -3.41% during the next 3 months and, with a 90% probability hold a price between $27.48 and $32.62 at the end of this 3-month period.

CLDX Signals & Forecast

Mostly positive signals in the chart today. The Celldex Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $30.45 and $31.38. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, June 08, 2026, and so far it has risen 13.17%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Celldex Therapeutics stock

Celldex Therapeutics finds support from accumulated volume at $31.37 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.03 between high and low, or 3.28%. For the last week, the stock has had daily average volatility of 3.71%.

Our recommended stop-loss: $31.21 (-3.42%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 6 days ago.)

Trading Expectations (CLDX) For The Upcoming Trading Day Of Wednesday 17th

For the upcoming trading day on Wednesday, 17th we expect Celldex Therapeutics to open at $32.06, and during the day (based on 14 day Average True Range), to move between $31.72 and $32.92, which gives a possible trading interval of +/-$1.20 (+/-3.77%) up or down from last closing price. If Celldex Therapeutics takes out the full calculated possible swing range there will be an estimated 3.77% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $32.41 (0.28%) than the support at $31.37 (2.94%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Celldex Therapeutics stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Current score: 3.177 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 17, 2026 - $32.06 ( 0.81%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk